CHELSEA PETROLIA: Open Payments
NPI 1821535006 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 59 payments from 15 companies in 2025. Trend: 2023 $657 · 2024 $1,025 · 2025 $1,308
Food & beverage: $1,308
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $247 |
| ABBVIE INC. | 9 | $174 |
| Janssen Biotech, Inc. | 9 | $161 |
| UROGEN PHARMA, INC. | 5 | $147 |
| BIOPROTECT MEDICAL, INC. | 1 | $141 |
| Dendreon Pharmaceuticals LLC | 4 | $86 |
| Olympus America Inc. | 5 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Laborie Medical Technologies Corp. | 1 | $53 |
| Boston Scientific Corporation | 1 | $34 |
Products named: GEMTESA, BOTOX, ERLEADA, BIOPROTECT BALLOON IMPLANT SYSTEM, PROVENGE, iTIND System, Nubeqa, JELMYTO.
Industry payments across LA — which companies pay providers there.
